http://ift.tt/2wwXqXw
To achieve its goal to reduce current breast cancer deaths in the U.S. by 50% by 2026, Komen is focusing on understanding the biology of metastatic breast cancer.
Social media
via MediaPost.com http://ift.tt/2nAOR8B
October 4, 2017 at 05:50AM
No comments:
Post a Comment